Accelerated approval positions RP1 plus nivolumab for advanced melanoma after progression on prior anti–PD-1 therapy, following two CRLs and a 10–3 advisory committee recommendation. In IGNYTE (n=140) ...
The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), ...
Katherine Wilemon, Family Heart Foundation, described the biggest unmet need when it comes to public awareness of Lp(a) and ...
Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results